Your browser doesn't support javascript.
loading
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit.
Oosting, S F; Barriuso, J; Bottomley, A; Galotti, M; Gyawali, B; Kiesewetter, B; Latino, N J; Martinelli, F; Pe, M; Pentheroudakis, G; Roitberg, F; Vachon, H; de Vries, E G E; Piccart, M; Cherny, N I.
Afiliação
  • Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: s.oosting@umcg.nl.
  • Barriuso J; The Christie NHS Foundation Trust and Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Electronic address: https://twitter.com/DrJorgeBarriuso.
  • Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. Electronic address: https://twitter.com/andrewbottom0.
  • Galotti M; ESMO Head Office, Lugano, Switzerland. Electronic address: https://twitter.com/MartinaGalotti.
  • Gyawali B; Department of Oncology, Queen's University, Kingston, Canada; Department of Public Health Sciences, Queen's University, Kingston, Canada; Division of Cancer Care and Epidemiology, Queen's University, Kingston, Canada. Electronic address: https://twitter.com/oncology_bg.
  • Kiesewetter B; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Latino NJ; ESMO Head Office, Lugano, Switzerland. Electronic address: https://twitter.com/NicolaJaneLatin.
  • Martinelli F; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Pe M; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. Electronic address: https://twitter.com/madeline_pe.
  • Pentheroudakis G; ESMO Head Office, Lugano, Switzerland. Electronic address: https://twitter.com/GPentheroudakis.
  • Roitberg F; WHO Cancer Management Consultant, Geneva, Switzerland; Hospital Sírio Libanês, São Paulo, Brazil. Electronic address: https://twitter.com/FroitbergM.
  • Vachon H; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: https://twitter.com/VriesElisabeth.
  • Piccart M; Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Cherny NI; Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. Electronic address: https://twitter.com/ChernyNathan.
Ann Oncol ; 34(4): 431-439, 2023 04.
Article em En | MEDLINE | ID: mdl-36549587
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article